Want to see HK:1830 full AI Analyst Report?
Top Page
Perfect Medical Health Management Limited
(1830)
Select Model
Select Model
Rating:77Outperform
Price Target:
HK$1.50
▲(20.00% Upside)
Action:Upgraded
Date:07/19/26
The score is driven primarily by solid financial performance (strong free cash flow and improved leverage) and attractive valuation (low P/E with a high dividend yield). Technicals are supportive with price above key moving averages and positive MACD, though near-overbought momentum readings temper the overall rating. The main fundamental risk is the two-year revenue decline and step-down in earnings versus prior periods.
Positive Factors
High Profitability Margins
Sustained high gross and operating margins indicate strong pricing power and service mix in aesthetic treatments. These margins provide buffer against cost volatility, support reinvestment in clinics and staff, and underpin durable earnings even if revenue growth slows.
Negative Factors
Declining Revenue Trend
Material top-line contraction erodes scale benefits and can pressure absolute profitability over time. Persistent revenue declines reduce ability to invest in marketing and new clinics, weaken pricing leverage, and raise the risk that margins and returns will compress if the trend continues.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability Margins
Sustained high gross and operating margins indicate strong pricing power and service mix in aesthetic treatments. These margins provide buffer against cost volatility, support reinvestment in clinics and staff, and underpin durable earnings even if revenue growth slows.
Read all positive factors
Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$1.63B
Dividend Yield11.45%
Average Volume (3M)657.70K
Price to Earnings (P/E)8.9
Beta (1Y)0.69
Revenue Growth-14.68%
EPS Growth-13.60%
CountryHK
Employees787
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.14
Shares Outstanding1,256,197,800
10 Day Avg. Volume240,700
30 Day Avg. Volume657,695
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)3.63
Price to Sales (P/S)1.46
P/FCF Ratio4.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.23
Revenue Forecast (FY)HK$1.22B
Perfect Medical Health Management Limited Business Overview & Revenue Model
Company Description
Operating as an investment holding firm, Perfect Medical Health Management Limited delivers a comprehensive suite of medical and aesthetic services across Hong Kong, mainland China, Macau, Singapore, and Australia. Its offerings encompass medical ...
How the Company Makes Money
The company primarily makes money by charging customers for services delivered at its medical beauty and health management centres, with revenue typically recognized when treatments are provided. Key revenue streams are expected to include fees fr...
Perfect Medical Health Management Limited Financial Statement Overview
Summary
Income Statement
64
Positive
Balance Sheet
78
Positive
Cash Flow
82
Very Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 962.35M | 1.13B | 1.39B | 1.39B | 1.35B |
| Gross Profit | 454.45M | 719.22M | 911.37M | 662.60M | 689.93M |
| EBITDA | 369.52M | 441.97M | 596.91M | 592.40M | 602.84M |
| Net Income | 178.72M | 206.90M | 315.80M | 315.64M | 305.25M |
Balance Sheet | |||||
| Total Assets | 834.20M | 935.91M | 1.22B | 1.30B | 1.28B |
| Cash, Cash Equivalents and Short-Term Investments | 294.93M | 386.80M | 567.40M | 656.85M | 454.37M |
| Total Debt | 134.58M | 216.65M | 268.73M | 240.35M | 311.07M |
| Total Liabilities | 446.33M | 557.18M | 725.00M | 684.02M | 786.93M |
| Stockholders Equity | 387.86M | 379.95M | 497.51M | 612.27M | 494.27M |
Cash Flow | |||||
| Free Cash Flow | 309.22M | 298.23M | 445.50M | 533.81M | 372.16M |
| Operating Cash Flow | 339.48M | 332.88M | 497.12M | 560.55M | 516.71M |
| Investing Cash Flow | -180.16M | -171.93M | 162.56M | -222.51M | 8.05M |
| Financing Cash Flow | -269.94M | -477.95M | -520.97M | -335.02M | -565.97M |
Perfect Medical Health Management Limited Technical Analysis
Negative
1.25
Price Trends
1.29
Negative
1.20
Positive
1.19
Positive
Market Momentum
<0.01
Positive
41.42
Neutral
45.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Negative. The current price of 1.25 is below the 20-day moving average (MA) of 1.32, below the 50-day MA of 1.29, and above the 200-day MA of 1.19, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 41.42 is Neutral, neither overbought nor oversold. The STOCH value of 45.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1830.
Perfect Medical Health Management Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.63B | 8.92 | 43.78% | 11.45% | -14.68% | -13.60% | |
61 Neutral | HK$6.03B | 14.12 | 6.50% | 20.98% | ― | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | HK$73.26M | -40.50 | -0.93% | 6.43% | -2.31% | 66.07% | |
43 Neutral | HK$1.84B | 51.13 | 6.47% | ― | 2.78% | -41.23% | |
41 Neutral | HK$154.40M | -16.11 | -61.33% | 3.14% | -38.43% | -394.12% | |
40 Underperform | HK$14.18M | -0.72 | -14.87% | ― | -26.00% | -188.55% |
* Healthcare Sector Average
HK:1830
Perfect Medical Health Management Limited
1.31
-0.08
-6.03%
HK:1448
Fu Shou Yuan International Group
2.64
-0.24
-8.24%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
>-0.01
-5.88%
HK:8296
Sino-Life Group Limited
0.15
-0.25
-62.50%
HK:8483
Max Sight Group Holdings Limited
0.18
0.08
81.19%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.96
0.65
208.06%
Perfect Medical Health Management Limited Corporate Events
Perfect Medical Sets August AGM to Approve Dividend, Board Re-elections and Share Mandate
Jul 15, 2026
Perfect Medical Health Management Limited has called an annual general meeting for 7 August 2026 in Hong Kong, where shareholders will review and adopt the audited financial statements for the year ended 31 March 2026 and consider a proposed final...
Perfect Medical Reports Double-Digit Sales Contract Growth on Economic Recovery
Jul 9, 2026
Perfect Medical Health Management Limited reported that the value of its sales contracts for the three months ended 30 June 2026 rose 12.1% from a year earlier, attributing the gain to a resilient recovery in the overall economy. The group signall...
Perfect Medical Chairman Boosts Personal Stake to Over 53 Percent
Jul 8, 2026
Perfect Medical Health Management Limited has issued a supplementary announcement detailing that Chairman and CEO Dr. Au-Yeung Kong personally acquired additional interests in the company’s controlling corporation on 6 July 2026 for HK$109,3...
Perfect Medical Chairman Lifts Stake to Majority Control While Maintaining Public Float
Jul 6, 2026
Perfect Medical Health Management Limited announced that chairman and chief executive officer Dr. Au‑Yeung Kong has increased his personal shareholding in the company. On 6 July 2026, he acquired additional interests in a controlling corpora...
Perfect Medical Narrows Revenue Decline and Lifts Margins While Maintaining 100% Payout
Jun 30, 2026
Perfect Medical Health Management Limited reported a 14.7% decline in revenue to HK$962.3 million for the year ended 31 March 2026, though the rate of decline narrowed to 6.1% in the second half as performance stabilised. Profit attributable to eq...
Perfect Medical Declares HKD 0.07 Final Dividend for FY2026
Jun 30, 2026
Perfect Medical Health Management Limited has declared a final ordinary cash dividend of HKD 0.07 per share for the financial year ended 31 March 2026, subject to shareholder approval on 7 August 2026. The dividend will be paid in Hong Kong dollar...
Perfect Medical Wins Shareholder Approval for New 2026 Option Scheme
Jun 18, 2026
Perfect Medical Health Management Limited secured strong shareholder backing at its 18 June 2026 extraordinary general meeting for a new 2026 Share Option Scheme, with a mandate limit set at 4.10% of issued shares, and for the termination of its e...
Perfect Medical Sets June Board Meeting to Approve 2026 Annual Results
Jun 17, 2026
Perfect Medical Health Management Limited has scheduled a board meeting for 30 June 2026 to review and approve the annual results for the financial year ended 31 March 2026. The board will also consider the possible declaration of a final dividend...
Perfect Medical Calls EGM to Adopt New Share Option Scheme and Grant Major Option Award
Jun 1, 2026
Perfect Medical Health Management Limited has called an extraordinary general meeting for 18 June 2026 in Hong Kong, where shareholders will vote on adopting a new 2026 Share Option Scheme. The proposed scheme will cap total issuable shares under ...
Perfect Medical Sets June EGM, Closes Register for Share Option Vote
May 29, 2026
Perfect Medical Health Management Limited will convene an extraordinary general meeting on 18 June 2026 to seek shareholder approval for a conditional grant of options under a new share option scheme. The company will close its register of members...
Perfect Medical Proposes New 2026 Share Option Scheme and Major Grant to Chairman
Apr 28, 2026
Perfect Medical Health Management Limited plans to terminate its existing 2021 share option scheme and replace it with a new 2026 share option scheme aligned with the latest Chapter 17 requirements of Hong Kong’s Listing Rules. Outstanding o...
Perfect Medical Overhauls Remuneration Committee to Strengthen Governance
Apr 22, 2026
Perfect Medical Health Management Limited has reshuffled its Remuneration Committee, with executive directors Dr. Au‑Yeung Kong, Ms. Au‑Yeung Wai and Mr. So Hin Lung stepping down as committee members effective 23 April 2026. The commi...
Perfect Medical Sets New Board and Committee Line‑Up for 2026
Apr 22, 2026
Perfect Medical Health Management Limited has announced the composition of its board of directors effective 23 April 2026, reaffirming Dr. Au‑Yeung Kong as chairman and chief executive officer alongside three other executive directors and fo...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.